<unk> , sold under the brand name Kineret, is a biopharmaceutical medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean fever, and Still's disease. It is a recombinant and slightly modified version of the human interleukin 1 receptor antagonist protein. It is marketed by Swedish Orphan Biovitrum.<unk>  is administered by subcutaneous injection.
Anakinra
Canakinumab
Sarilumab
Crofelemer
Tofacitinib
Ecallantide
Emapalumab
Anifrolumab